JP2022508825A5 - - Google Patents
Info
- Publication number
- JP2022508825A5 JP2022508825A5 JP2021546200A JP2021546200A JP2022508825A5 JP 2022508825 A5 JP2022508825 A5 JP 2022508825A5 JP 2021546200 A JP2021546200 A JP 2021546200A JP 2021546200 A JP2021546200 A JP 2021546200A JP 2022508825 A5 JP2022508825 A5 JP 2022508825A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- conjugate according
- seq
- hvr
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862747070P | 2018-10-17 | 2018-10-17 | |
| US62/747,070 | 2018-10-17 | ||
| US201862747611P | 2018-10-18 | 2018-10-18 | |
| US62/747,611 | 2018-10-18 | ||
| PCT/US2019/056619 WO2020081744A1 (en) | 2018-10-17 | 2019-10-16 | Immunomodulating polynucleotide conjugates and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022508825A JP2022508825A (ja) | 2022-01-19 |
| JP2022508825A5 true JP2022508825A5 (https=) | 2022-10-21 |
| JP7536025B2 JP7536025B2 (ja) | 2024-08-19 |
Family
ID=70284225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021546200A Active JP7536025B2 (ja) | 2018-10-17 | 2019-10-16 | 免疫調節性ポリヌクレオチドコンジュゲートと使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220096649A1 (https=) |
| EP (1) | EP3866858A4 (https=) |
| JP (1) | JP7536025B2 (https=) |
| KR (1) | KR20210102204A (https=) |
| CN (1) | CN113660955A (https=) |
| AU (1) | AU2019360216A1 (https=) |
| BR (1) | BR112021007294A2 (https=) |
| CA (1) | CA3116880A1 (https=) |
| IL (1) | IL282282B2 (https=) |
| MX (1) | MX2021004365A (https=) |
| SG (1) | SG11202103805SA (https=) |
| WO (1) | WO2020081744A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019012295A (es) | 2017-04-14 | 2020-02-07 | Tollnine Inc | Polinucleotidos inmunomoduladores, conjugados de anticuerpos de los mismos y metodos para su uso. |
| CA3169523A1 (en) | 2020-02-28 | 2021-09-02 | Jaume Pons | Transglutaminase-mediated conjugation |
| KR20240083868A (ko) * | 2021-08-20 | 2024-06-12 | 탈락 테라퓨틱스, 인크. | 넥틴-4 항체 및 접합체 |
| MX2024002407A (es) * | 2021-08-25 | 2024-05-15 | Tallac Therapeutics Inc | Anticuerpos y conjugados sirp-alfa. |
| WO2023081934A1 (en) * | 2021-11-08 | 2023-05-11 | The University Of Chicago | Methods and compositions for pkc-delta inhibition and cancer immunotherapy |
| KR20250039518A (ko) * | 2022-05-18 | 2025-03-20 | 탈락 테라퓨틱스, 인크. | 항-cd22 항체 올리고뉴클레오타이드 접합체를 사용하여 암을 치료하는 방법 |
| WO2025157804A1 (en) * | 2024-01-24 | 2025-07-31 | F. Hoffmann-La Roche Ag | Linkers for site-specific protein conjugation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3066105A4 (en) * | 2013-11-06 | 2017-10-11 | Solstice Biologics, Ltd. | Polynucleotide constructs having disulfide groups |
| CA2950960A1 (en) * | 2014-06-06 | 2015-12-10 | Solstice Biologics, Ltd. | Polynucleotide constructs having bioreversible and non-bioreversible groups |
| US20180134802A1 (en) * | 2016-01-08 | 2018-05-17 | The University Of North Carolina At Charlotte | Compositions comprising chimeric antigen receptors, t cells comprising the same, and methods of using the same |
| AU2017221437A1 (en) * | 2016-02-19 | 2018-08-23 | Genisphere Llc | Nucleic acid carriers and therapeutic methods of use |
| JOP20190009A1 (ar) * | 2016-09-21 | 2019-01-27 | Alx Oncology Inc | أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها |
-
2019
- 2019-10-16 JP JP2021546200A patent/JP7536025B2/ja active Active
- 2019-10-16 AU AU2019360216A patent/AU2019360216A1/en active Pending
- 2019-10-16 BR BR112021007294-2A patent/BR112021007294A2/pt unknown
- 2019-10-16 MX MX2021004365A patent/MX2021004365A/es unknown
- 2019-10-16 WO PCT/US2019/056619 patent/WO2020081744A1/en not_active Ceased
- 2019-10-16 CA CA3116880A patent/CA3116880A1/en active Pending
- 2019-10-16 IL IL282282A patent/IL282282B2/en unknown
- 2019-10-16 CN CN201980082021.3A patent/CN113660955A/zh active Pending
- 2019-10-16 SG SG11202103805SA patent/SG11202103805SA/en unknown
- 2019-10-16 US US17/283,919 patent/US20220096649A1/en not_active Abandoned
- 2019-10-16 EP EP19874575.4A patent/EP3866858A4/en active Pending
- 2019-10-16 KR KR1020217014643A patent/KR20210102204A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022508825A5 (https=) | ||
| HRP20201144T1 (hr) | Protutijela anti-cd3 i postupci uporabe | |
| CN105585630B (zh) | 具有修改的等电点的抗体 | |
| JP2024524222A5 (https=) | ||
| JP2020523319A5 (https=) | ||
| JP2023503943A5 (https=) | ||
| JP2020505330A5 (https=) | ||
| EP3774921A1 (en) | Antibody variable domains targeting dll3, and use thereof | |
| US20240228645A1 (en) | Antibodies targeting baff-r and use thereof | |
| JP2022521240A5 (https=) | ||
| CN113660955A (zh) | 免疫调节性多核苷酸缀合物及其使用方法 | |
| JP2024514530A5 (https=) | ||
| JP2024520902A5 (https=) | ||
| JP2022550243A5 (https=) | ||
| JP2022532991A5 (https=) | ||
| JP2024535705A5 (https=) | ||
| IL297435A (en) | Compounds and methods for modulating atxn1 | |
| JP2022535060A (ja) | 選択的に切断可能なリンカーを有する二重特異性結合構築物 | |
| US20250277024A1 (en) | Molecules with multiple binding domains | |
| CN118974258A (zh) | 抗fap-alpha的人源抗体 | |
| WO2025151406A1 (en) | Chemically modified oligonucleotides and conjugates and methods thereof | |
| WO2025235515A1 (en) | Activatable polypeptide complex formulations | |
| US20230203198A1 (en) | Bispecific binding constructs | |
| RU2022115671A (ru) | Моноклональное антитело или его антигенсвязывающий фрагмент, которое специфически связывается с BCMA, и его применение | |
| JP2025504955A5 (https=) |